Search results for " Drug"

showing 10 items of 3138 documents

Therapeutic Monitoring of Aripiprazole by HPLC with Column-Switching and Spectrophotometric Detection

2005

Aripiprazole is a novel atypical antipsychotic drug for the treatment of schizophrenia and schizoaffective disorders (1)(2)(3). The drug is metabolized by the cytochrome P450 isoenzymes 3A4 and 2D6 (4). Because of high interindividual variability in the expression of these enzymes, the aripiprazole concentration varies among healthy individuals after administration of the drug (5). In patients, insufficient response or side effects, such as somnolence, akathisia, or nausea, may result from too low or too high drug concentrations. Therapeutic drug monitoring (TDM), which is established practice for many antipsychotic drugs (6)(7), may be helpful for patients treated with aripiprazole. We mea…

DrugPerphenazinemedicine.drug_classmedia_common.quotation_subjectClinical BiochemistryAripiprazoleAtypical antipsychoticQuinolonesPharmacologyPartial agonistHigh-performance liquid chromatographyPiperazinesmedicineHumansChromatography High Pressure Liquidmedia_commonmedicine.diagnostic_testChemistryReboxetineBiochemistry (medical)Therapeutic drug monitoringSchizophreniaSpectrophotometry UltravioletAripiprazoleDrug MonitoringAntipsychotic Agentsmedicine.drugClinical Chemistry
researchProduct

Utilizing inherent fluorescence of therapeutics to analyze real-time uptake and multi-parametric effector kinetics.

2011

Abstract The precise detection of pharmaceutical drug uptake and knowledge of a drug’s efficacy at the single-cell level is crucial for understanding a compound’s performance. Many pharmaceutical drugs, like the model substances Doxorubicin, Mitoxantrone or Irinotecan, have a distinctive natural fluorescence that can be readily exploited for research purposes. Utilizing this respective natural fluorescence, we propose a method analyzing simultaneously in real-time the efficiency, effects and the associated kinetics of compound-uptake and efflux in mammalian cells by flow cytometry. We show that real-time flow cytometric quantification of compound-uptake is reliably measured and that analyzi…

DrugPharmaceutical drugCell Survivalmedia_common.quotation_subjectmedicine.medical_treatmentKineticsAntineoplastic AgentsComputational biologyBiologyPharmacologyIrinotecanGeneral Biochemistry Genetics and Molecular BiologyFluorescenceFlow cytometryCell Line TumormedicineHumansMolecular Biologymedia_commonmedicine.diagnostic_testEffectorBiological TransportFlow CytometryFluoresceinsFluorescenceDrug Resistance MultipleMultiple drug resistanceKineticsDoxorubicinDrug Resistance NeoplasmCamptothecinEffluxMitoxantroneSingle-Cell AnalysisReactive Oxygen SpeciesMethods (San Diego, Calif.)
researchProduct

Selected cytotoxic gold compounds cause significant inhibition of 20S proteasome catalytic activities

2014

Abstract Six structurally diverse cytotoxic gold compounds are reported to cause profound and differential inhibition of the three main catalytic activities of purified 20S proteasome whilst auranofin , an established gold(I) drug in clinical use, is nearly ineffective. In particular, the gold(I) complex [( pbiH ) Au ( PPh 3 )] PF 6 , turns out to be the most potent inhibitor of all three enzyme activities with sub-micromolar IC 50 values. The present results further support the view that proteasome inhibition may play a major – yet not exclusive – role in the cytotoxic actions of gold based anticancer agents.

DrugProteasome Endopeptidase ComplexAuranofinmedia_common.quotation_subjectAntineoplastic AgentsPharmacologyBiochemistry20s proteasomeProteasome Gold compounds Anticancer drugs Enzyme inhibitionCatalysisInorganic ChemistryInhibitory Concentration 50Structure-Activity RelationshipGold CompoundsCoordination ComplexesAuranofinmedicineHumansCytotoxic T cellmedia_commonchemistry.chemical_classificationCytotoxinsChemistryEnzymeProteasomeBiochemistryBiocatalysisOrganogold CompoundsProteasome Inhibitorsmedicine.drug
researchProduct

Learning to be a psychostimulants addict with self-regulation therapy

2018

This article presents the results of a single-case experiment of alternative treatments in which a participant applied the Self-Regulation Therapy (SRT) to reproduce the effects of a stimulant drug, methylphenidate, and a sedative, alcohol. The SRT is a learning procedure based on classic conditioning and suggestion that reproduces the effect of drugs by remembering the effects they have. The participant reproduced the effects of both drugs during ten sessions held on 5 consecutive days. To record effects, adjective scales were used that measured Drug effect, High, Rush, Energy, Tension and the General Factor of Personality (GFP). The results indicated that the participant was capable of in…

DrugPsychotherapistmedicine.drug_classmedia_common.quotation_subjectAddictionSelf-Regulation TherapyUNESCO::FILOSOFÍA:FILOSOFÍA [UNESCO]medicineInverted uDrug effectmedia_commonSensitization drugMethylphenidateClassical conditioningGeneral MedicineTerapèuticaGeneral Factor of PersonalityTolerance drugSedativeMethylphenidateDroguesPersonalitatStimulant drugPsychologyAlcoholMATEMATICA APLICADAMedicamentsmedicine.drug
researchProduct

Perspiration versus saliva--basic aspects concerning their use in roadside drug testing.

1999

Various aspects concerning the practical application and forensic interpretation of data obtained by saliva drug testing and drug monitoring from the skin surface are discussed. Basic information on the composition of saliva and skin secretions and their particular transport mechanisms, as far as known, are given. For drugs of abuse secretion into saliva is suggested to be by passive diffusion and to depend on lipid solubility, pKa, plasma protein binding and on the pH of saliva. Drug molecules from blood are considered to reach the skin surface by various routes such as by sweat and sebum as well as by inter- and/or transcellular diffusion. The role of the stratum corneum as a temporary dr…

DrugSalivaDrugs of abuseintegumentary systemChemistryIllicit Drugsmedia_common.quotation_subjectPharmacologySensitivity and SpecificityPathology and Forensic MedicineSubstance Abuse Detectionmedicine.anatomical_structureSkin surfaceDrug reservoirStratum corneummedicineHumansCocaine metabolitesPerspirationmedicine.symptomDrug MonitoringSalivaSweatmedia_commonInternational journal of legal medicine
researchProduct

Caffeine and cardiovascular diseases: critical review of current research.

2015

Caffeine is a most widely consumed physiological stimulant worldwide, which is consumed via natural sources, such as coffee and tea, and now marketed sources such as energy drinks and other dietary supplements. This wide use has led to concerns regarding the safety of caffeine and its proposed beneficial role in alertness, performance and energy expenditure and side effects in the cardiovascular system. The question remains "Which dose is safe?", as the population does not appear to adhere to the strict guidelines listed on caffeine consumption. Studies in humans and animal models yield controversial results, which can be explained by population, type and dose of caffeine and low statistica…

DrugSettore BIO/17 - Istologiamedia_common.quotation_subjectmedicine.medical_treatmentPopulationMedicine (miscellaneous)030204 cardiovascular system & hematologyCoffeeToxicology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMeta-Analysis as TopicEnvironmental healthCaffeinemedicineAnimalsHumanseducationmedia_commonMetabolic Syndromeeducation.field_of_studyNutrition and DieteticsDose-Response Relationship Drugbusiness.industryClinical Studies as TopicInsulin sensitivityHeartStimulantAlertnessDisease Models AnimalEnergy expenditurechemistryCaffeine consumptionCardiovascular diseases Caffeine Cardioprotective effects Pathogenesis Clinical studies Experimental studiesCardiovascular DiseasesBlood VesselsCaffeinebusiness030217 neurology & neurosurgeryEuropean journal of nutrition
researchProduct

Drugs and the Colon

1983

It is not our intention to review drug effects in the colon, which was done extensively and profoundly by Forth and Rummel1 and Powell.2 Our contribution will present studies of drug effects on physiological absorption and secretion processes obtained in the intact human colon and based on results of intestinal perfusion studies of the whole colon and measurements of transepithelial electrical potential difference (PD) in the rectosigmoid colon. These are at present the practiced and—regarding perfusion studies—most accurate techniques in the hands of clinicians to directly study drug effects on a local dose-response scale in the intact human colon. Since these methods are relatively new an…

DrugStudy drugbusiness.industryPhysiological Absorptionmedia_common.quotation_subjectRectosigmoid ColonBioinformaticsClinical researchExtensive dataMedicinebusinessPerfusionHuman colonmedia_common
researchProduct

Carbamazepine transbuccal delivery: the histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmu…

2009

Transbuccal drug delivery is an attractive way of administration since several well-known advantages are provided, especially with respect to peroral management. Carbamazepine (CBZ) is an anticonvulsant which is useful in controlling neuropathic pain, and it is currently administered by peroral route, although its absorption and bioavailability is limited due to various factors. The oral cavity could be an interesting site for transbuccal CBZ delivery due to two properties: slow administration of constant low drug doses and less dose-related side effects. However, in transbuccal absorption a major limitation could be the low permeability of the mucosa which results in low drug bioavailabil…

DrugSwinemedicine.medical_treatmentmedia_common.quotation_subjectImmunologyAbsorption (skin)PharmacologyPermeabilitymedicineImmunology and AllergyAnimalsHumansmedia_commonPharmacologyChemistryMouth MucosaCarbamazepineBuccal administrationEpitheliumCarbamazepine Transbuccal drug delivery Porcine buccal mucosa Reconstituted human oral epithelium Trigeminal neuralgiaBioavailabilityAnticonvulsantmedicine.anatomical_structureCarbamazepineCheekDrug deliveryAnticonvulsantsmedicine.drugInternational journal of immunopathology and pharmacology
researchProduct

Novel inulin-based mucoadhesive micelles loaded with corticosteroids as potential transcorneal permeation enhancers

2017

In this work a new copolymer of inulin (INU) derivatized with ethylendiamine (EDA) and retinoic acid (RA), named INU-EDA-RA, was synthetized, characterized and employed to produce micelles as carriers for topical administration of corticosteroids for the potential treatment of diseases of posterior eye segment. Spectroscopic analysis confirmed a molar derivatization degree of 11.30 and 4.30% in EDA and RA, respectively. INU-EDA-RA micelles are capable of strong mucoadhesive interactions which result time-independent and stable over time but concentration depending. Moreover micelles are able to encapsulate efficiently from 3 to 13% (w/w) of lipophilic drugs, as dexamethasone, triamcinolone …

DrugTriamcinolone acetonideTranscorneal enhancerCell SurvivalSwineAdministration Topicalmedia_common.quotation_subjectTranswellPharmaceutical ScienceMucoadhesionRetinal Pigment Epithelium02 engineering and technologyOcular disease030226 pharmacology & pharmacyMicellePermeabilityCorneaMice03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesPolymeric micelleRetinoic acidCell AdhesionMucoadhesionmedicineCorticosteroidAnimalsHumansDissolution testingOcular topical administrationMicellesmedia_commonDrug CarriersChromatographyDose-Response Relationship DrugChemistryInulinGeneral Medicine021001 nanoscience & nanotechnologyPermeability (electromagnetism)Cattle0210 nano-technologyDrug carrierDrug metabolismBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Rash and multiorgan dysfunction following lamotrigine: could genetic be involved?

2015

We report the case of a 38-year-old woman treated with lamotrigine who experienced multi-organ dysfunction. The patient received the drug at the dose of 100 mg per day. One week later, the treatment was suspended because of an extensive body rash. Twenty-four hours later, the patient appeared drowsy and stuporous and was hospitalized. On the fifth day, the patient was admitted with a clinical picture of acute multi-organ failure in our Institute, where, she, despite the support of vital functions with vasoactive drugs, continuous hemofiltration and ventilation with oxygen, died. Serum lamotrigine concentration was measured 110 h after its last dose and the drug resulted to be still present …

DrugUGT1A4Genotypemedia_common.quotation_subjectMultiple Organ FailurePharmaceutical ScienceSNPPharmacyLamotrigineToxicologyLamotriginePolymorphism Single NucleotideVasoactiveRashmedicineHumansPharmacology (medical)GlucuronosyltransferaseUGT2B7media_commonPharmacologybusiness.industryTriazinesPharmacogeneticMultiorgan dysfunctionABCB1ExanthemaRashHLAMulti-organ dysfunctionAnesthesiaBreathingSettore BIO/14 - FarmacologiaAnticonvulsantsFemaleUGT1A4medicine.symptombusinessPharmacogeneticsAntiepileptic drugmedicine.drug
researchProduct